p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney Disease
Björn Meijers(VIB-KU Leuven Center for Microbiology), Pieter Evenepoel(KU Leuven), Dirk Kuypers(KU Leuven), Kathleen Claes(KU Leuven), Yves Vanrenterghem(KU Leuven), Bert Bammens(KU Leuven), Henriëtte de Loor, Liesbeth Viaene, Kristin Verbeke(KU Leuven)
Cited by 309
Related Papers
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
|New England Journal of Medicine|2004|1.1k
Short chain fatty acids in human gut and metabolic health
|Beneficial Microbes|2020|1.1k
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
|Kidney International|2017|998
Uremic toxins originating from colonic microbial metabolism
|Kidney International|2009|442